Last checked at 1 Nov 2019 15:32
Faron Pharmaceuticals Unable To Explain Significant Shares Price Surge
Faron Pharmaceuticals Unable To Explain Significant Shares Price Surge
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Faron Pharma Share News (FARN)
FARN Share
Price
FARN Share
News
FARN Share
Chat
FARN Share
Trades3
FARN
Live RNS
FARN Share
Charts
FARN Level 2
Console
FARN Live
Share Price
FARN Broker
Ratings
FARN Directors
Deals
FARN Financial
Diary
FARN
Fundamentals
FARN Short
Positions
FARN
Media
Faron Pharma Information
Share Price Information for Faron Pharma (FARN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
127.50
Bid:
120.00
Ask:
135.00
Change:
0.00 (0.00%)
Spread:
15.00 (12.50%)
Open:
127.50
High:
127.50
Low:
127.50
Prev. Close:
127.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.9 Oct 2019 14:05
Faron Pharmaceuticals positive on feedback from 'Clevegen' monitoring committee
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced feedback from the 'MATINS' study data monitoring committee on Wednesday, from the ongoing dose escalation study from part 1 of the MATINS trial.
Read more9 Oct 2019 09:18
Faron Pharmaceuticals To Test New Lower Dose In Clevegen Study
Faron Pharmaceuticals To Test New Lower Dose In Clevegen Study
Read more2 Oct 2019 14:57
Faron Pharmaceuticals hits bump in road for Traumakine manufacturing
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Wednesday that, further to its update in its interim results in relation to the active pharmaceutical ingredient (API) manufacturing process for 'Traumakine', Rentschler Biopharma has sent Faron a letter in which it terminated the agreement concerning the API manufacturing.
Read more2 Oct 2019 13:13
Manufacturer Ends Traumakine Agreement With Faron Pharmaceuticals
Manufacturer Ends Traumakine Agreement With Faron Pharmaceuticals
Read more23 Sep 2019 11:37
Faron Pharmaceuticals Ends Traumakine Trial; Loss Narrows On Expenses
(Alliance News) - Faron Pharmaceuticals Oy on Monday said its loss narrowed considerably in the first half of 2019, after it cut back on research & development spending and opted to end a firm
Read more16 Sep 2019 15:59
UK Earnings, Trading Statements Calendar - Next 7 Days
Tuesday 17 September JTCHalf Year ResultsStafflineHalf Year GroupHalf Year Year
Read more27 Aug 2019 16:34
Faron Pharma raises ?2.3m to keep it going through the start of 2020
(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals has received valid acceptances and excess applications from qualifying shareholders for a total of 859,513 open offer shares, raising gross proceeds of around €1.01m (£0.92m) at the issue price of 106p per share and at the euro issue price of 119 cents per share, it announced on Tuesday.
Read more27 Aug 2019 11:38
Faron Pharma Raises EUR2.5 Million; Now Has Working Capital To 2020
(Alliance News) - Faron Pharmaceuticals Oy on Tuesday said it has raised EUR2.5 million via share subscription and open offer.The company raised EUR1.0 million from the issue of 859,513 at
Read more5 Aug 2019 12:26
Faron Pharmaceuticals To Raise EUR2.1 Million For Clevegen Development
(Alliance News) - Faron Pharmaceuticals Oy on Monday announced a EUR1.1 million subscription and EUR2.0 million open offer to fund the clinical development of cancer drug Clevegen.Shares in
Read more12 Jul 2019 10:35
WINNERS & LOSERS SUMMARY: Thomas Cook Plunges On Rescue Deal Talks
(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------BHP up 1.5%. The -
Read more12 Jul 2019 10:20
Faron Pharma Pleased By MATINS Progress And Plans To Increase Capacity
(Alliance News) - Faron Pharmaceuticals Oy said on Friday its MATINS study of nine cancer patients is progressing well, and it is planning to expand the clinical trial to more countries.The
Read more26 Jun 2019 11:52
Faron Pharmaceuticals Says Traumakine Study Hindered By Steroid Use
(Alliance News) - Faron Pharmaceuticals Oy on Wednesday said interim results from its phase two Inforaaa study support continuation but the study is limited by a lack of patients not also taking a
Read more14 Jun 2019 11:54
Faron Pharmaceuticals' Analysis Explains "Disappointing" Prior Trial
(Alliance News) - Faron Pharmaceuticals Oy on Friday said analysis of a more recent trial of Traumakine has explained why the drug did not perform as expected in a previous trial.Shares in
Read more14 Jun 2019 10:37
Faron Pharmaceuticals reports 'significant' findings from YODA study
(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced results from its pharmacokinetic/dynamic 'YODA' study examining the administration of concomitant steroids and Traumakine in healthy volunteers on Friday.
Read more